# Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit

> **NCT04210427** · PHASE4 · COMPLETED · sponsor: **St. Louis University** · enrollment: 3 (actual)

## Conditions studied

- Cystic Fibrosis Gastrointestinal Disease

## Interventions

- **DRUG:** Polyethylene Glycol 3350
- **DEVICE:** SmartPill Motility System & PillCam Patency Capsule

## Key facts

- **NCT ID:** NCT04210427
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-12
- **Primary completion:** 2023-06-06
- **Final completion:** 2023-06-06
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04210427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04210427, "Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04210427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*